Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system

被引:0
作者
Nico Melzer
Sven G. Meuth
Heinz Wiendl
机构
[1] University of Münster,Department of Neurology, Inflammatory Disorders of the Nervous System and Neurooncology
[2] Department of Physiology I,undefined
[3] Neuropathophysiology,undefined
来源
Journal of Neurology | 2013年 / 260卷
关键词
Cancer; Autoimmunity; Neurons; Encephalitis; Antibodies; Cytotoxic T cells; Ion channels; Neurotransmitter receptors;
D O I
暂无
中图分类号
学科分类号
摘要
Autoimmune central nervous system (CNS) inflammation occurs both in a paraneoplastic and non-paraneoplastic context. In a widening spectrum of clinical disorders, the underlying adaptive (auto) immune response targets neurons with a divergent role for cellular and humoral disease mechanisms: (1) in encephalitis associated with antibodies to intracellular neuronal antigens, neuronal antigen-specific CD8+ T cells seemingly account for irreversible progressive neuronal cell death and neurological decline with poor response to immunotherapy. However, a pathogenic effect of humoral immune mechanisms is also debated. (2) In encephalitis associated with antibodies to synaptic and extrasynaptic neuronal cell surface antigens, potentially reversible antibody-mediated disturbance of synaptic transmission and neuronal excitability occurs in the absence of excessive neuronal damage and accounts for a good response to immunotherapy. However, a pathogenic effect of cellular immune mechanisms is also debated. We provide an overview of entities, clinical hallmarks, imaging features, characteristic laboratory, electrophysiological, cerebrospinal fluid and neuropathological findings, cellular and molecular disease mechanisms as well as therapeutic options in these two broad categories of inflammatory CNS disorders.
引用
收藏
页码:1215 / 1233
页数:18
相关论文
共 760 条
  • [81] Vernino S(2001)Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies Ann Neurol 50 339-52
  • [82] Lennon VA(2010)Molecular and clinical diversity in paraneoplastic immunity to Ma proteins Ther Adv Neurol Disord 3 43-2563
  • [83] Coesmans M(2008)Progress in the management of paraneoplastic neurological disorders Brain 131 2553-1418
  • [84] Smitt PA(2003)Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association Brain 126 1409-22
  • [85] Linden DJ(2010)Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients Immunol Res 46 12-753
  • [86] Shigemoto R(2002)Regulating functional cell fates in CD8 T cells J Neurol 249 745-27
  • [87] Hirano T(2000)Survival and outcome in 73 anti-Hu-positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy N Engl J Med 342 21-1560
  • [88] Yamakawa Y(1990)Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor N Engl J Med 322 1555-1020
  • [89] van Alphen AM(1988)Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome N Engl J Med 318 1012-1411
  • [90] Luo C(2005)Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus Lancet 365 1406-551